The potential reassessment of cannabinoids, particularly at the federal level, is generating considerable anticipation within the sector. A shift away from Schedule I status, often considered as outdated and hindering https://webcastlist.com/story22163692/cannabinoid-rescheduling-a-growth-catalyst